Literature DB >> 12670839

Early death due to severe organophosphate poisoning is a centrally mediated process.

Steven B Bird1, Romolo J Gaspari, Eric W Dickson.   

Abstract

OBJECTIVE: To distinguish whether early death from severe organophosphate (OP) poisoning with dichlorvos is mediated through peripheral or central nervous system (CNS) actions.
METHODS: Wistar rats (n = 72) were randomized to pretreatment with either: normal saline (controls), peripheral anticholinergics (glycopyrrolate [low, medium, or high dose] or nebulized ipratropium bromide), or CNS + peripherally acting anticholinergics (diphenhydramine, nebulized atropine, or injected atropine). All treatments were given prior to a subcutaneous injection of 25 mg/kg dichlorvos (n = 8 per group). Survival was assessed at 10 minutes (early death) and 24 hours (delayed death). Kaplan-Meier (95% confidence intervals [95% CIs]) and chi-squared analysis was then performed to determine differences between treatments.
RESULTS: Regardless of treatment, all animals exhibited profound nicotinic effects (fasciculations) without obvious seizures within 2 minutes of poisoning. In rats pretreated with peripherally acting agents, the fasciculations were rapidly followed by reduced motor activity, sedation, and death. Mortality at 10 minutes for saline controls, glycopyrrolate, and ipratropium was 88%, 96%, and 100%, respectively. The single control animal surviving beyond 10 minutes went on to develop peripheral cholinergic manifestations, including hypersalivation, urination, and defecation. Only one of 24 animals treated with injected atropine, nebulized atropine, or diphenhydramine died during the early phase of poisoning; all others survived to 24 hours (p < 0.01).
CONCLUSIONS: Death in acute, severe OP poisoning is prevented by pretreatment with anticholinergic agents that cross the blood-brain barrier, but not by agents with only peripheral actions. Early death due to OP poisoning appears to be a centrally mediated process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670839     DOI: 10.1111/j.1553-2712.2003.tb01338.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  24 in total

1.  Non-muscarinic therapeutic targets for acute organophosphorus poisoning.

Authors:  Christopher Rosenbaum; Steven B Bird
Journal:  J Med Toxicol       Date:  2010-12

2.  Pharmacokinetics of OpdA, an organophosphorus hydrolase, in the African green monkey.

Authors:  Colin J Jackson; Colin Scott; Angela Carville; Keith Mansfield; David L Ollis; Steven B Bird
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

3.  Use of OpdA, an organophosphorus (OP) hydrolase, prevents lethality in an African green monkey model of acute OP poisoning.

Authors:  Colin J Jackson; Angela Carville; Jeanine Ward; Keith Mansfield; David L Ollis; Tejvir Khurana; Steven B Bird
Journal:  Toxicology       Date:  2014-01-18       Impact factor: 4.221

Review 4.  Comparison of current recommended regimens of atropinization in organophosphate poisoning.

Authors:  Nicholas J Connors; Zachary H Harnett; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2014-06

5.  Kinetics and efficacy of an organophosphorus hydrolase in a rodent model of methyl-parathion poisoning.

Authors:  Chip Gresham; Christopher Rosenbaum; Romolo J Gaspari; Colin J Jackson; Steven B Bird
Journal:  Acad Emerg Med       Date:  2010-07       Impact factor: 3.451

Review 6.  Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication.

Authors:  Michelle Guignet; Kiran Dhakal; Brenna M Flannery; Brad A Hobson; Dorota Zolkowska; Ashish Dhir; Donald A Bruun; Shuyang Li; Abdul Wahab; Danielle J Harvey; Jill L Silverman; Michael A Rogawski; Pamela J Lein
Journal:  Neurobiol Dis       Date:  2019-03-21       Impact factor: 5.996

7.  Comparison of two commonly practiced atropinization regimens in acute organophosphorus and carbamate poisoning, doubling doses vs. ad hoc: a prospective observational study.

Authors:  P M S Perera; S Shahmy; I Gawarammana; A H Dawson
Journal:  Hum Exp Toxicol       Date:  2008-06       Impact factor: 2.903

8.  Protective effects of the antihistamine promethazine aginst acute paraxon-methyl and dicrotophos toxicity in adult rats.

Authors:  Syed M Nurulain; Shreesh Ojha; Mohammad Shafiullah; Nadia Khan; Murat Oz; Bassem Sadek
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrier.

Authors:  Ruben J Boado; Yun Zhang; Yufeng Zhang; Yuntao Wang; William M Pardridge
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

Review 10.  Enhancing organophosphate hydrolase efficacy via protein engineering and immobilization strategies.

Authors:  Priya Katyal; Stanley Chu; Jin Kim Montclare
Journal:  Ann N Y Acad Sci       Date:  2020-08-19       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.